David Stanton
Stock Analyst at Jefferies
(4.08)
# 1,601
Out of 4,361 analysts
207
Total ratings
43%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by David Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Downgraded: Hold | $195.00 → $108.00 | $92.08 | +17.30% | 23 | May 29, 2026 | |
| ASX: HLS Healius Limited | Maintained: Hold | $0.81 → $0.45 | $0.325 | +38.46% | 16 | May 13, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Maintained: Buy | $3.05 → $3.30 | $2.90 | +13.99% | 17 | May 5, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $40.00 → $39.20 | $8.90 | +340.45% | 10 | Apr 24, 2026 | |
| ASX: COH Cochlear Limited | Maintained: Buy | $285.00 → $137.00 | $95.40 | +43.61% | 18 | Apr 23, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $24.30 → $27.40 | $12.20 | +124.59% | 22 | Apr 15, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Buy | $1.10 → $0.90 | $0.707 | +27.30% | 9 | Apr 13, 2026 | |
| ASX: MSB Mesoblast Limited | Maintained: Buy | $3.30 → $2.80 | $2.04 | +37.59% | 15 | Apr 9, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $25.60 → $22.55 | $18.80 | +19.95% | 19 | Mar 25, 2026 | |
| ASX: IMM Immutep Limited | Downgraded: Hold | $2.10 → $0.04 | $0.051 | -21.57% | 8 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.60 → $27.00 | $13.62 | +98.31% | 16 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $5.00 | $2.32 | +115.98% | 11 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38.65 → $34.50 | $36.44 | -5.32% | 11 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 → $3.50 | $2.04 | +71.57% | 8 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.52 | n/a | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.49 | n/a | 3 | Apr 8, 2021 |
CSL Limited
May 29, 2026
Downgraded: Hold
Price Target: $195.00 → $108.00
Current: $92.08
Upside: +17.30%
Healius Limited
May 13, 2026
Maintained: Hold
Price Target: $0.81 → $0.45
Current: $0.325
Upside: +38.46%
Sigma Healthcare Limited
May 5, 2026
Maintained: Buy
Price Target: $3.05 → $3.30
Current: $2.90
Upside: +13.99%
Clinuvel Pharmaceuticals Limited
Apr 24, 2026
Maintained: Buy
Price Target: $40.00 → $39.20
Current: $8.90
Upside: +340.45%
Cochlear Limited
Apr 23, 2026
Maintained: Buy
Price Target: $285.00 → $137.00
Current: $95.40
Upside: +43.61%
Telix Pharmaceuticals Limited
Apr 15, 2026
Maintained: Buy
Price Target: $24.30 → $27.40
Current: $12.20
Upside: +124.59%
Monash IVF Group Limited
Apr 13, 2026
Maintained: Buy
Price Target: $1.10 → $0.90
Current: $0.707
Upside: +27.30%
Mesoblast Limited
Apr 9, 2026
Maintained: Buy
Price Target: $3.30 → $2.80
Current: $2.04
Upside: +37.59%
Sonic Healthcare Limited
Mar 25, 2026
Maintained: Hold
Price Target: $25.60 → $22.55
Current: $18.80
Upside: +19.95%
Immutep Limited
Mar 13, 2026
Downgraded: Hold
Price Target: $2.10 → $0.04
Current: $0.051
Upside: -21.57%
Feb 5, 2026
Maintained: Buy
Price Target: $28.60 → $27.00
Current: $13.62
Upside: +98.31%
Dec 16, 2025
Upgraded: Buy
Price Target: $5.00
Current: $2.32
Upside: +115.98%
Aug 28, 2025
Maintained: Hold
Price Target: $38.65 → $34.50
Current: $36.44
Upside: -5.32%
Aug 26, 2025
Maintained: Buy
Price Target: $3.30 → $3.50
Current: $2.04
Upside: +71.57%
Dec 6, 2022
Downgraded: Hold
Price Target: n/a
Current: $14.52
Upside: n/a
Apr 8, 2021
Downgraded: Hold
Price Target: n/a
Current: $13.49
Upside: n/a